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A B S T R A C T
Boron is an essential element for plants and probably essential for human and animal health. Boron has a broad
range of physiological effects on biological systems at low concentrations, whereas it is toxic to at high con-
centrations. Eventhough there are many studies on boron’s biological effects and toxicity, more information is
needed to understand the mechanisms of its action. The aim of the current work is to review boron’s function,
transport and toxicity in different biological systems.
1. General properties and chemistry of boron
Boron is a metalloid located on group 13 in the periodic table with
atomic number 5, atomic mass 10.811 g/mol and chemical symbol B.
Although boron compounds have been known for centuries, it was first
discovered as an element by Sir Humphry Davy and by Gay-Lussac and
Thenard in 1808 [1].
Boron has different isotopes, among which 10B and 11B are the most
stable ones. Boron is not present in an elemental form in nature, rather
it forms organoboron complexes with sodium and oxygen, which are
the physiologically important forms of boron in organisms [2]. Al-
though boron has a low abundance when compared with the hydrogen,
carbon, nitrogen, or oxygen, it is common in the environment and
naturally found in rocks, soil, and water [3,4].
Organoboron complexes, which contain B-O or B-N bonds like or-
thoborates, are important in biological systems. These organoboron
complexes are formed in plant, animal, and human tissues. In an or-
ganism nearly 96% of the boron is present as an uncharged boric acid B
(OH)3 and as a small amount of borate anion B(OH)4−[1,2,5]. Boric
acid is a weak Lewis acid with a pKa of 9.25. This pKa value decreases
when boron forms covalent bonds with its ligands, and it becomes ne-
gatively charged tetrahedral borate anion B(OH)4–[2].
Both boric acid and borate make reversible interactions with bio-
molecules which contain adjacent cis-hydroxyl groups such as ribo-
flavin, adenosine monophosphate, pyridoxine, pyrimidine nucleotides,
ascorbic acid, and five carbon sugar molecules such as ribose, apiose,
and polysaccharides. Borate also binds to NAD+ in animals and affects
its functions [6–9]. Such an affinity may be responsible for biological
effects of boric acid [1]. Boric acid and the sodium salts of boron
(borax, disodium tetraborate) are commonly used as an antiseptic,
bactericide, cleaning agent such as soaps and detergents, preservatives,
fire retardants, fertilizers, insecticides and herbicides. Boron is also
used in many industrial applications including glass production, fi-
berglass insulation, porcelain enamel, ceramic glazes, and metal alloys
[3,10].
Major world boron deposits are located in Turkey and USA, and are
also found in Argentina, Chile, Russia, China, Peru, Egypt, Iraq, Libya,
Morocco and Syria [11].
2. Boron requirement of microorganisms
Boron has important roles in physiological and metabolic activities
of microbial systems [11]. The first natural compound found to contain
boron is the antibiotic Boromycin (produced by Streptomyces anti-
bioticus) acting on gram-positive bacteria [12]. In addition, boron is
present in the bacterial antibiotics tartrolons (produced by Sorangium
cellulosum) [13,14], borophisin, aplasmomycin (produced by Strepto-
myces griseus) [2,15,16]; the bacterial quorum sensing molecule auto-
inducer AI-2 [17]; a boron containing siderophore vibrioferrin, which is
produced by a marine bacterium [18]; and in borolithochromes, which
are responsible for the pink color of the algae Solenopora jurassica [19].
Boron is required for bacterial nitrogen fixation in Azotobacter [20].
Bacillus boroniphilus requires boron for its growth and can tolerate more
than 450 mM boron [21]. Heterocystous cyanobacteria and actinomy-
cetes of the genus Frankia also require boron for both growth and ni-
trogen fixation. Some species of Cyanobacteria contain heterocysts
which are specific cells for nitrogen fixation. Boron was suggested to
interact and stabilize the glycolipids of the heterocysts [1,2,22,23].
Boron is also required for lower eukaryotes such as brown algae,
diatoms and algal flagellates [2,24,25]. Additionally, the yeast
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Saccharomyces cerevisiae, which is a unicellular eukaryote, needs boron
for its growth. Bennett showed that yeast cells can not divide under
boron deficiency. When boron was added back to the media, yeast cells
proliferated normally, however when the boron levels increased in the
environment they could not grow well [26]. It has been also revealed
that yeast can survive up to 80 mM boric acid and it has been con-
sidered as a boron tolerant species. Yeast is a suitable model for in-
vestigating the molecular biology of the boron [27,28].
3. Boron roles in plants
According to the Warington’s report in 1923, growth of Vicia faba
(field bean) was reduced in a medium that lacked boron, but when the
medium was supplied with boron the growth was rescued [29]. Since
that time boron has been accepted as a necessary and beneficial mi-
croelement for various organisms. In plants, boron is considered to have
important roles in nucleic acid metabolism, carbohydrate and protein
metabolism, cell wall synthesis, cell wall structure, membrane integrity
and function, and phenol metabolism [30,31]. However, the molecular
mechanisms of these functions are largely not known.
A primary function of boron at molecular level is that it cross-links
pectins in plant cell walls. Pectins are complex polysaccharides and
they are important components of plant cell wall structure. Borate
forms a cross-link with apiose residues of pectin rhamnogalacturonanII
(RG-II), which is essential for cell wall stability and normal leaf ex-
tension [32,33]. RG-II is a pectic polysaccharide which covalently binds
to borate esters with cis-diol bounds [34]. Borate crosslinking in this
pectic system strengthens cell wall physically and plays important roles
in cell adhesion [35,36].
In plants, boron has important roles in expanding organs, for this
reason, the symptoms of boron deficiency can be mainly observed in
expanding organs. Boron deficiency results in the formation of ab-
normal cell wall, altered cytoskeletal polymerization, and changes in
plasma membrane permeability. In addition leaf expansion, root elon-
gation, flower and fruit development are inhibited [4,37]. Boron de-
privation interferes with many physiological processes such as sugar
metabolism, carbohydrate metabolism, RNA metabolism, phenol me-
tabolism, and cell wall structure [4,38]. In 2004, it was reported that
the expression of glutathione S-transferase and glucosyltransferase was
induced in tobacco (Nicotiana tabacum) BY-2 cells under boron limita-
tion [39]. In 2009, another study with the same cells showed that
oxidative damage was directly involved in cell death under boron de-
privation and it was not likely a typical programmed cell death [40].
4. Boron in human and animal health
Boron and its compounds have been known for a while as beneficial
for the metabolism of humans and animals. An essentiality of boron for
human has not been reported, instead it is considered as a probably
essential element by the WHO [41].
It has roles in steroid hormone metabolism, healthy bone develop-
ment, and cell membrane maintenance [11,42]. People consume many
products containing boron in their daily life; one can get 1–7 mg boron
daily. It exists abundantly in vegetables, fruits, nuts, and their by-pro-
ducts [43,44]. In healthy people boron levels change between 15 and
80 μg/kg [45]. Boron is absorbed from gastrointestinal tract completely
and present in body as boric acid [7].
In animals boron affects various mechanisms which include carbo-
hydrate, mineral metabolism, energy consumption, regulation of sev-
eral enzyme activities and embryonic development [11]. Boron depri-
vation affects the reproduction and development in organisms
including frogs, zebrafish, rat, and mice [4,46–48]. It is also necessary
during the embryonic development of zebra fish (Danio rerio) [49],
rainbow trout (Oncorhynchus mykiss) [46] and frogs (Xenopus laevis)
[47].
High amounts of boron are reported to interfere with the
development of some organs of chicken and rat immune system [50]. It
was found that long term excess boron intake of African ostrich Struthio
camelus resulted in the resistance of thymus to boron stress [51]. It is
known that boron is involved in inflammatory response by suppressing
the activities of specific enzymes in some inflammatory diseases (joint
swelling). 6-phosphogluconate, which is a pentose phosphate pathway
constituent, forms complex with boron and subsequently inhibits 6-
phosphogluconate dehydrogenase enzyme in the same pathway. Pen-
tose phosphate pathway is involved in the respiratory burst mechanism
in which phagocytes need more oxygen due to the production of re-
active oxygen species (ROS). Therefore, it is hypothesized that ROS
production in leukocytes may be reduced through the inhibitory actions
of boron on 6-phosphogluconate dehydrogenase so that the arthritic
symptoms may be relaxed [7].
There are also studies suggesting the limiting effects of boron by
inducing the antioxidant defense mechanisms that can destroy ROS
[52,53]. Natural (i.e. sodium borate) and synthetic (i.e. peptide boronic
acid) boron compounds have been shown to inhibit serine proteases
such as chymotrypsin, cathepsin G, elastase in a reversible manner in
vitro [7,54,55]. The inhibition of serine proteases in coagulation system
by boron, which is another way of action of boron in inflammatory
response, has also been suggested [56]. The prostaglandins, leuko-
trienes, and thromboxanes are involved in the inflammation response
and lipoxygenase is necessary for these components. This enzyme is
inhibited by boron in cultured human leukocytes [7,57,58].
Boron was also shown to regulate extracellular matrix by directly
affecting the activities of some enzymes such as elastase, trypsin-like
enzymes, collagenase. It also induces the release of TNF-α in fibroblasts
[59]. Gene expression levels of some of the bone tissue related extra-
cellular matrix proteins such as collagen type I (COLI), osteopontin
(OPN), osteocalcin (OCN), bone sialoprotein (BSP) increase by boron
treatment [60,61]. By the action of boron on extracellular matrix, it has
been also suggested that boron may also improve the wound healing
[62]. In one of the studies, it was reported that an antimicrobial hy-
drogel which contains boron was found to be successful in the healing
of burn wound in in vitro [63].
The mineral part of bone is composed of mainly calcium and
phosphate. Boron has been found beneficial for calcium metabolism
and bone metabolism accordingly. Different metals in the bloodstream
such as aluminum, boron, cadmium, chromium, and lead show an af-
finity to skeletal tissue during mineral removal of bone [61,64–66].
Boron is beneficial for the bone formation and composition especially in
regulating the hormones that support the bone growth [61,67]. A study
conducted with postmenopausal women showed that more boron in-
take causes more plasma estrogen and testosterone and less calcium
excretion. In the postmenopausal period, bone loss was observed in
women due to the reduced estrogen levels. Gallardo-Williams suggested
that an increase of boron in diet resulted in an enhancement of plasma
17β-estradiol and testosterone levels and an impediment of calcium
excretion in urine [65]. There are also supportive results from animal
studies. For example, dietary supplementation of boron on pigs,
chicken, and rats has shown to promote bone strength [65,68–70]. It
was firstly proposed that boron has positive effects on bone miner-
alization in chickens that have Vitamin D deficient diet [4,67].
There are several experimental and epidemiological studies showing
the positive effects of boric acid on human prostate cancer cells
[6,42,71]. When boric acid was supplemented in the diet of mice
having impaired immune system, the human prostate cancer tumors
that had been transplanted to mice showed decreased growth [72]. It
also inhibits the growth and the proliferation of prostate cancer cell
lines DU-145, and LNCaP in a dose dependent manner [49,73]. When
considering the molecular markers of proliferation and senescence,
boric acid was found to reduce the cyclin A-E, MAPK proteins and in-
duce a senescent-like morphology rather than cell death in DU-145 cells
[71]. Increased concentrations of boric acid were shown to bind NAD+
and inhibit the NAD+ induced Ca2+ release in DU-145 cells [6]. It was
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shown that boric acid can bind to cADRP (cyclic ADP ribose) which is
an agonist of ryanodine receptor, when present in excess. It was pro-
posed that boric acid binds to a site on the ryanodine receptor so that it
can keep Ca2+ channel inactive [74,75]. When ER Ca2+ levels de-
crease due to the inactivation of Ca2+ channel; ER stress, formation of
cytoplasmic stress granules, and eIF2α/ATF4 pathway are induced ac-
cordingly in DU-145 prostate cells treated with physiological amounts
of boric acid [76]. Studies also show that boric acid and phenylboronic
acid affect the actin arrangement and thereby decrease the cell mi-
gration in DU-145 prostate cancer cells. Phenylboronic acid was found
to be a more potent inhibitor of the cancer cell migration [77,78].
There is also evidence that the intake of boron with the diet reduces
the risks of lung and breast cancers in women [36,79]. Boric acid is
effectively used in vaginal yeast infections especially caused by the
dimorphic fungus Candida albicans [80]. Boric acid was shown to cause
defects in cytokinesis and thus, the stabilization of cytoskeleton is im-
paired at bud neck in Saccharomyces cerevisae [81]. Unlike S. cerevisiae,
the hyphal cytoskeleton was disrupted by boric acid in Candida albicans.
It was suggested that boric acid exhibits these effects by impairing the
actin organization in these yeasts [82].
Aflatoxins are produced by the fungus Aspergillus. They can con-
taminate food products and when consumed some of them have car-
cinogenic effects on animals and humans. It is suggested that boric acid
has potential as a protective agent for DNA against oxidative damage
caused by Aflatoxin B1 [83,84].
Boron deprivation results in impairment of growth, abnormal bone
development, decrease in blood steroid hormone levels, increase in
urinary calcium excretion, and changes in macromineral status in hu-
mans and animals [85]. It is also found that mice and frogs have de-
velopmental disorders arising from boron deficiency [86]. Boron defi-
ciency was also shown to reduce osteogenesis in rat and mice models
[87]. Boron has been known to play roles in the metabolism of other
substances such as calcium, magnesium, triacylglycerols, glucose,
amino acids, reactive oxygen species, hormones such as 17β-estradiol,
calcitonin, 25-hydroxycholecalciferol [4,88].
Boron deprivation has been shown to cause photophobia which is
photoreceptor dystrophy in the zebrafish [4,46]. In addition, it is found
that in animals and humans, boron deficiency is also related to the
decrease in the electrical activity of brain, short term memory, and
decrease in skills in performing tasks whereas the boron supplementa-
tion increases brain functions. These effects of boron could be attrib-
uted to the changes in membranes providing nerve-impulse transmis-
sion by boron [4,89,90]. Boron deficiency is also suggested to be the
possible causal agents in Kashin-Beck disease which is a bone disease
having a high incidence in China [91].
5. Boron toxicity and tolerance mechanisms
Both boron deficiency and toxicity may have negative outcomes for
the metabolism of plants and animals [92,93]. In general, metalloids
lead to toxicity by affecting different cellular mechanisms in biological
systems. The causes of metalloid toxicity can include an increase in
oxidative system, DNA damage, impairment of DNA repair systems and
membrane functions, or the inhibition of protein folding, protein
function and activities. Cells develop various mechanisms to cope with
this toxicity caused by metalloids such as export of the metalloid out of
the cell, the storage of the metalloid in intracellular organelles, de-
crease of the import by the metalloid binding proteins and peptides
[94–96].
Studies carried out to understand the molecular mechanisms of
boron toxicity have revealed that there is a relation between the ex-
pression of boron efflux pump ATR1 and the expression of amino acid
biosynthesis genes [97]. This mechanism is strictly regulated by the
transcription factor Gcn4 in response to boron stress. eIF2α provides
the delivery of charged methionyl initiator tRNA to the initiation codon
and forms a ternary complex with GTP. It is a multimeric protein and is
phoshorylated on serine-51 of its α subunit in response to viral infec-
tion, amino acid limitation, apoptosis, nutrient deprivation, heme de-
privation, and other stresses [98]. Boron induces the phosphorylation of
eIF2α in a Gcn2 protein kinase dependent manner, interferes with the
initiation of translation, resulting in the inhibition of protein synthesis
[97].
In addition, to find out the genes that play roles in boron metabo-
lism, a haploid yeast deletion collection was screened for the genes that
confer boron resistance or sensitivity to yeast cells. 21 boron sensitive
and 6 boron resistant mutants were found. Additionally proteomic
analyses showed that there are proteins whose expression increases in
the presence of toxic levels of boric acid. All these genes and proteins
indicate different pathways within the cell, which needs further in-
vestigation [99].
High concentrations of boron are generally used to control bacterial
and fungal infections. The toxic activity of boric acid is suggested to be
especially on mitochondria and mitochondrial enzymes in Saprolegnia
which is a fungus and causes saprolegniasis in fish and fish eggs [100].
Boron may also be also toxic for humans. Humans consume boron
daily, mostly from fruits and vegetables. When consumed at high doses,
it can cause developmental and reproductive abnormalities [44]. A
study on rats revealed that the lowest observed adverse effect level
(LOAEL) of boron for developmental toxicity was 13.3 mg/kg body
weight/day and the no observable adverse effect level (NOAEL) was
9.6 mg/kg body weight/day [44,101]. People who work in boron mine
plants have a mean blood boron level of 224 ng/g and show no
symptoms of toxicity [102]. Reports suggest that environmental or in-
dustrial boron exposure is not a treat for human health [103,104].
There is only limited number of cases for boron intoxication invol-
ving human subjects. Oral exposures of humans to high levels of boric
acid have resulted in little or no observable toxicity, as seen in acci-
dental poisonings up to 88 gr, of which 90% of the cases were
asymptomatic [105]. Oral intake of boron by two infants resulted in
anemia, seizures, erythema and scanty hair over several weeks [88]. A
mid-age man who drank two cups of boric acid powder died on the
third day of intake due to cardiac problems. His blood boron level was
about 42 mg/dL after 52 h of intake [106]. However, gastrointestinal,
cardiovascular, hepatic, renal, and central nervous system effects,
dermatitis, erythema, and death have been observed in children and
adults exposed to ≥84 mg boron/kg [106–109]. Chronic exposure to
boron causes neurological effects, kidney damage, diarrhea, anorexia,
weight loss, and testicular atrophy [88]. Based on the accidental poi-
soning results, acute lethal dose of boron is estimated to be around 20 g
for adults.
Boron toxicity in plants is a relatively common issue in dry areas
where soil boron levels are high. Some of the symptoms observed in
boron toxicated plants are altered metabolism, lowered growth rates in
shoots and roots, decreased levels of chlorophyll and lignin [110,111].
Boron most likely exerts its toxic activity in plants by either changing
the cell wall structure or by binding to cis-diol containing sugars such as
ribose moiety in metabolically important nucleotides [112].
6. Boron uptake and transport mechanisms
To maintain the boron homeostasis, boron levels that are trans-
ported inside or outside of the cell should be regulated by cellular
mechanisms. The effects of boron can be observed primarily in plants
since they are exposed to boron directly from the soil. Thus, many plant
genes have been identified related to boron transport and tolerance
mechanisms. Plants absorb boron from soil in the form of boric acid. It
is taken up by roots and is loaded to xylem for transport to shoots.
During this long distance transport boron follows the transpiration
streams and accumulates at margins of mature leaves [113]. For the
uptake of boron from the soil there are evidences for both passive and
active transport. Boric acid is a small uncharged molecule and its vo-
lume (71.5 Å) is nearly the same as urea (75.3 Å) [4,110,114]. The
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studies conducted with squash root (Cucurbita pepo) and charopyte alga
(Chara corallina) [115] cells revealed that the permeability coefficient
of boric acid for lipid bilayer is 8 × 10−6 cm/s [116,117]. Thus, under
high boron supply, passive diffusion represents a significant way for
boron to pass the root epidermis.
When availability of boron is low in the soil, there is a need for
membrane proteins to uptake boron, which indicate the presence of
active transport mechanisms. Many plant genes related to boron
transport and tolerance, have been identified [118,119]. Boric acid is
transported against its concentration gradient in sunflower (Helianthus
annuus) in low boron conditions [120]. Similar to the sunflowers Ara-
bidopsis thaliana accumulates boron in the xylem against a concentra-
tion gradient under boron limitation. BOR1, a boron efflux transporter,
is responsible for this xylem loading [121]. A.thaliana bor1-1 mutant
[122] can not translocate boron from roots to shoots thereby shoot
growth can be inhibited under low boron conditions [123]. BOR1 is
degraded in the vacuole following endocytosis when plants are exposed
to high levels of boron [124]. BOR1 belongs to animal bicarbonate
transporter superfamily (SLC4) and its homologs have been found in
many organisms such as rice OsBOR1, yeast YNL275w,and mammalian
NaBC1 [122,125,126].
Yeast has been used as a model organism for the characterization of
many plant boron tolerant genes. Yeast BOR1 is localized to plasma
membrane and has a role in boric acid efflux [127]. In addition to
BOR1, DUR3 and FPS1 are found to be involved in boron tolerance in
yeast. However, the functions of these transporters in boron detox-
ification are not clear [28]. ATR1 was found as the major boron tol-
erance gene in yeast [27]. It is composed of 14 membrane spanning
domains and a member of the DHA2 family of drug-H+ antiporters
[128]. It reduces the intracellular boron levels and provides extreme
resistance to boron [27]. Bioinformatics analyses showed that
YMR279C and YOR378W were the two paralogs of ATR1 gene. The
expression of YMR279C decreased the intracellular boron levels and
provided remarkable boron resistance to the yeast cells [129]. NaBC1 is
a voltage regulated bicarbonate sodium coupled borate cotransporter
and it is identified as one of the BOR1 homologs in mammalian system
and it improves the cell proliferation when boron concentrations are
low [75,126]. AtBOR1 has six homologs in A. thaliana genome and only
AtBOR4 shows tolerance to boron when overexpressed in A. thaliana
under high boron conditions through boron efflux [31]. Besides A.
thaliana, VvBOR1 and CmBOR1 have been characterized as boron
transporters in Vitis vinifera and Citrus macrophylla [130,131]. In crop
plants, BOT1, which is a BOR1 ortholog, provides boron tolerance to
barley [132].
The membrane transport of boric acid is also facilitated by the
special channel proteins, NIP5:1. NIP5:1 belongs to plant-specific no-
dulin 26-like intrinsic proteins (NIP) subfamily and has been identified
as a boric acid channel that is upregulated in A. thaliana roots under
boron deficiency [133]. It is also a member of major intrinsic protein
family (MIP) proteins and serves as channels for water and small un-
charged molecules in mammals, amphibians, yeast, bacteria and plants
[134]. However, it is unclear whether other MIPs are involved in boric
acid transport in animals. Vacuolar compartmentation of boron has
been also reported in A. thaliana and Citrus macrophylla by the activity
of TIP5, aquaporin family member localized in cell tonoplast membrane
[135,136]. Overexpression of AtTIP5:1 lowers to boron concentration in
cytoplasm by transferring boron to vacuole [136]. Vacuolar membrane
proton pumps, especially tonoplast adenosine triphosphatase subunit E
(V-ATPase E) and tonoplast pyrophosphatase (V-PPiase), change their
expression under boron or salt toxicity [137,138].
The information about physiology and molecular biology of boron
uptake in humans and animals is limited. Boron is ingested from the
diet [139]. It does not tend to accumulate in tissues. However bone,
nails, and hair have been found to have higher boron levels, whereas fat
tissue has low boron levels [140]. Boron is rapidly absorbed from the
human intestine and then is excreted completely in the urine
[4,44,65,141].
7. Conclusions
Boron occurs naturally in soils, rocks, and water bodies. In certain
places of the World it is found at high concentrations. It is used com-
monly in agriculture due to its roles in plant growth and development.
Boron deficiency and toxicity result in growth impairment in plants,
which causes especially agricultural and economic loss in many parts of
the World. Understanding the true mechanisms of boron action may
improve crop yield.
Not only plants but also many organisms need boron for their me-
tabolic activities. They have to acquire sufficient amounts of boron
while protecting themselves from the toxic effects of it. For many years,
boron has been used as a pesticide, antifungal and antimicrobial agent.
Additional roles of boron have been revealed recently. For example, it
has supporting roles in plant cell wall; it acts as a communicating signal
molecule in quorum sensing mechanism.
Research on animal, plant, and cell cultures has showed that boron
impairs the enzyme activities either directly or indirectly by binding to
their cofactors (i.e. NAD) or in a way which is unknown yet
[2,142,143]. Since it interferes with many metabolites, it can make
changes in mineral and energy metabolisms both in humans and ani-
mals [4,144]. It has crucial roles in bone metabolism by interacting
other minerals and vitamins such as calcium, magnesium and vitamin D
and hormones which are important for bone formation [61,65,145]. It
also reduces the risk of inflammatory diseases [4]. There are increasing
evidences on the usage of boron in medicine. One of the supporting
facts is the acceptance of bortezomib (Velcade®) which is a boron
containing drug for the treatment of multiple myeloma by the US Food
and Drug Administration (FDA). It acts as a reversible inhibitor of the
proteosome in mammalian cells [146]. Accumulating evidences suggest
that boron and boron containing molecules may offer to be natural
anticancer agent or potential drugs in daily diet. However, for boron to
become useful for the health, the mechanisms of its action and the risk
of toxicity should be enlightened with new approaches both in vitro and
in vivo.
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